Neogenomics (NEO) FCF Margin Growth (3y) (2013 - 2026)
Neogenomics (NEO) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 221.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -921.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 819.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -891.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 175.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 3,681.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 896.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 327.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 54.00 |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | 1,198.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,198.00 |
| Mar 31, 2026 | 945.00 |
| Dec 31, 2025 | 249.00 |
| Sep 30, 2025 | 1,903.00 |
| Jun 30, 2025 | 2,954.00 |
| Mar 31, 2025 | 1,405.00 |
| Dec 31, 2024 | 2,422.00 |
| Sep 30, 2024 | 1,782.00 |
| Jun 30, 2024 | 1,917.00 |
| Mar 31, 2024 | -837.00 |
| Dec 31, 2023 | 1,128.00 |
| Sep 30, 2023 | -59.00 |
| Jun 30, 2023 | -254.00 |
| Mar 31, 2023 | -550.00 |
| Dec 31, 2022 | -338.00 |
| Sep 30, 2022 | -2,954.00 |
| Jun 30, 2022 | -1,379.00 |
| Mar 31, 2022 | -3,483.00 |
| Dec 31, 2021 | -4,126.00 |
| Sep 30, 2021 | -2,776.00 |